A 6-Month Consumer Behavior Study of a Self-Management System (0803-084)(COMPLETED)

Merck Sharp & Dohme LLC1,000 enrolled

Overview

The purpose of this study is to evaluate the ability of patients with intermediate risk of heart disease to appropriately use a Self-Management System.

The duration of treatment is 6 months.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

1,000

Conditions

Hypercholesterolemia

Interventions

MK0803, lovastatinDRUG

Self-Management SystemBEHAVIORAL

Eligibility

Sex: ALLMin age: 45 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Must be able to read and understand English without assistance. * For Males: Minimum age 45 years and Maximum age N/A (No limit). * For Females: Minimum age 55 years and Maximum age N/A (No limit). Exclusion Criteria: * Pregnant or nursing * Drug allergy

Outcomes

Primary Outcomes

Percentage of patients who make appropriate decision for self-management.

Secondary Outcomes

Percentage of patients who make appropriate decision to discontinue therapy or consult with a physician; the incidence of adverse experiences.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.